Literature DB >> 15838801

Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels.

Marek Radkowski1, Andrzej Horban, Juan F Gallegos-Orozco, Agnieszka Pawelczyk, Joanna Jablonska, Jeffrey Wilkinson, Debra Adair, Tomasz Laskus.   

Abstract

It is unclear whether patients who test positive for anti-hepatitis C virus (HCV) antibodies and have normal alanine aminotransferase (ALT) levels remain infected with the virus. Eleven patients who tested positive for anti-HCV antibodies, had persistently normal ALT levels, and tested negative for HCV RNA by commercial test were studied. Serum and peripheral blood mononuclear cells (PBMCs) were collected 2-3 times at 3-6-month intervals, and PBMCs were cultured with phytohemagglutinin and pokeweed mitogen. HCV RNA was detected in serum samples from 6 (55%) and in PBMCs from 11 (100%) patients. Our results suggest that, in asymptomatic patients who test positive for anti-HCV antibodies, small quantities of HCV RNA commonly persist, even in patients who test negative for HCV RNA in serum by commercial tests.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838801     DOI: 10.1086/429834

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Vertical transmission of the hepatitis C virus: Current knowledge and issues.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

2.  Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses.

Authors:  Naga Suresh Veerapu; Sukanya Raghuraman; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

3.  Does occult hepatitis C virus infection exist?

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  J Clin Microbiol       Date:  2008-10       Impact factor: 5.948

4.  New perspectives in occult hepatitis C virus infection.

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

5.  Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.

Authors:  Ghada Abdelmoemen; Samy Abdelkader Khodeir; Sabry Abou-Saif; Abdelrahman Kobtan; Sherief Abd-Elsalam
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-06       Impact factor: 4.223

6.  Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection.

Authors:  F Nesrine; H Saleh
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

7.  Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection.

Authors:  Bahman Khalvati Fahlyani; Abbas Behzad-Behbahani; Seiied Alireza Taghavi; Ali Farhadi; Saeede Salehi; Setare Adibzadeh; Farzaneh Aboualizadeh; Parniyan Alavi; Negin Nikouyan; Mohammad Ali Okhovat; Reza Ranjbaran; Gholam Reza Rafiei Dehbidi; Arash Shakibzadeh
Journal:  Hepat Mon       Date:  2015-08-31       Impact factor: 0.660

8.  Occult HCV infection: an unexpected finding in a population unselected for hepatic disease.

Authors:  Laura De Marco; Anna Gillio-Tos; Valentina Fiano; Guglielmo Ronco; Vittorio Krogh; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Franco Merletti; Lorenzo Richiardi; Carlotta Sacerdote
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

9.  Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease.

Authors:  Laura De Marco; Paola Manzini; Morena Trevisan; Anna Gillio-Tos; Franca Danielle; Cinzia Balloco; Alessandra Pizzi; Eleonora De Filippo; Sergio D'Antico; Beatrice Violante; Adriano Valfrè; Franco Curti; Franco Merletti; Lorenzo Richiardi
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  Occult hepatitis C virus infection in Iranian hemodialysis patients.

Authors:  Ali Eslamifar; Amitis Ramezani; Hassan Ehteram; Effat Razeghi; Farrokhlagha Ahmadi; Manouchehr Amini; Mohammad Banifazl; Gelavizh Etemadi; Hossein Keyvani; Anahita Bavand; Arezoo Aghakhani
Journal:  J Nephropathol       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.